NCT02132858View on ClinicalTrials.gov

Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 8, 2022

Study Completion Date

October 31, 2022

Conditions
Mucinous Adenocarcinoma of the RectumRecurrent Rectal CancerSignet Ring Adenocarcinoma of the RectumStage IIA Rectal CancerStage IIB Rectal CancerStage IIC Rectal CancerStage IIIA Rectal CancerStage IIIB Rectal CancerStage IIIC Rectal Cancer
Interventions
OTHER

cytology specimen collection procedure

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT02132858 - Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation | Biotech Hunter | Biotech Hunter